CAD 0.07
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - CAD | 0.0% |
2022 | - CAD | 0.0% |
2021 | - CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | - CAD | 0.0% |
2024 Q1 | - CAD | 0.0% |
2024 Q2 | - CAD | 0.0% |
2023 FY | - CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2023 Q4 | - CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2023 Q1 | - CAD | 0.0% |
2022 Q2 | - CAD | 0.0% |
2022 Q1 | - CAD | 0.0% |
2022 FY | - CAD | 0.0% |
2022 Q4 | - CAD | 0.0% |
2022 Q3 | - CAD | 0.0% |
2021 Q1 | 464.56 Thousand CAD | 20.44% |
2021 Q3 | - CAD | -100.0% |
2021 FY | - CAD | 0.0% |
2021 Q4 | - CAD | 0.0% |
2021 Q2 | 260.4 Thousand CAD | -43.95% |
2020 Q2 | 391.65 Thousand CAD | 167.28% |
2020 Q3 | 641.56 Thousand CAD | 63.81% |
2020 Q4 | 385.73 Thousand CAD | -39.88% |
2020 FY | - CAD | 0.0% |
2020 Q1 | 146.53 Thousand CAD | 459.56% |
2019 Q1 | 100.93 Thousand CAD | 212.27% |
2019 FY | - CAD | 0.0% |
2019 Q2 | 70.73 Thousand CAD | -29.92% |
2019 Q3 | 60.76 Thousand CAD | -14.09% |
2019 Q4 | 26.18 Thousand CAD | -56.91% |
2018 Q3 | 41.03 Thousand CAD | -4.3% |
2018 Q1 | 53.09 Thousand CAD | -21.96% |
2018 Q2 | 42.88 Thousand CAD | -19.23% |
2018 Q4 | 32.32 Thousand CAD | -21.24% |
2018 FY | - CAD | 0.0% |
2017 Q4 | 68.02 Thousand CAD | -20.83% |
2017 FY | - CAD | 0.0% |
2017 Q2 | 94.28 Thousand CAD | 158.0% |
2017 Q1 | 36.54 Thousand CAD | -53.85% |
2017 Q3 | 85.92 Thousand CAD | -8.86% |
2016 Q1 | - CAD | 0.0% |
2016 Q3 | 107.53 Thousand CAD | -50.05% |
2016 Q4 | 79.18 Thousand CAD | -26.37% |
2016 FY | - CAD | 0.0% |
2016 Q2 | 215.27 Thousand CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Asep Medical Holdings Inc | - CAD | NaN% |
BetterLife Pharma Inc. | - CAD | NaN% |
BioVaxys Technology Corp. | - CAD | NaN% |
ChitogenX Inc. | - CAD | NaN% |
Rapid Dose Therapeutics Corp. | 132.46 Thousand CAD | 100.0% |
Defence Therapeutics Inc. | -35.44 Thousand CAD | 100.0% |
Entheon Biomedical Corp. | -6233.00 CAD | 100.0% |
Gemina Laboratories Ltd. | - CAD | NaN% |
Glow Lifetech Corp. | 120.53 Thousand CAD | 100.0% |
Lexston Life Sciences Corp. | 46.03 Thousand CAD | 100.0% |
Pharmala Biotech Holdings Inc. | 122.19 Thousand CAD | 100.0% |
Doseology Sciences Inc. | 39.7 Thousand CAD | 100.0% |
MYND Life Sciences Inc. | - CAD | NaN% |
Nova Mentis Life Science Corp. | -6970.00 CAD | 100.0% |
PharmaTher Holdings Ltd. | -8330.00 CAD | 100.0% |
PreveCeutical Medical Inc. | - CAD | NaN% |
Telescope Innovations Corp. | - CAD | NaN% |